Drug Shortage Report for APO-ELETRIPTAN
| Report ID | 123558 |
| Drug Identification Number | 02386062 |
| Brand name | APO-ELETRIPTAN |
| Common or Proper name | ELETRIPTAN |
| Company Name | APOTEX INC |
| Market Status | DORMANT |
| Active Ingredient(s) | ELETRIPTAN |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 6 BLS |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-08-31 |
| Estimated end date | 2021-11-19 |
| Actual end date | 2021-11-18 |
| Shortage status | Resolved |
| Updated date | 2021-11-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.